| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| North America (Primary) | PRIMARYNOAM | Univ | 7,783 | 74,818,897 | 0.18% | 1.71% | -3.95% | -4.31% | -1.42% | 26.75% |
| Healthcare | HEALTHCARE | Sector | 1,212 | 6,835,435 | -0.56% | 1.10% | -5.40% | -6.58% | 3.05% | 14.17% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 608 | 3,778,036 | -1.18% | 1.94% | -3.75% | 1.74% | 15.37% | 40.68% |
| Other Biopharmaceuticals | BIOPHARMAOTHER | Industry | 105 | 1,507,638 | -1.28% | 0.61% | -4.39% | 7.34% | 12.60% | 42.40% |
| Transplantation Biopharmaceuticals | TRANSPLANTATION | SubInd | 4 | 3,314 | 1.06% | 2.89% | 10.44% | 11.90% | 65.10% | 98.17% |
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Syndax Pharmaceuticals, Inc. | SNDX:USASNDX:USA | Stock | 1 | 2,186 | 5.32% | 1.82% | 16.33% | 18.08% | 62.89% | 93.91% |
| Transplantation Biopharmaceuticals | TRANSPLANTATION | SubInd | 4 | 3,314 | 1.06% | 2.89% | 10.44% | 11.90% | 65.10% | 98.17% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,024 | 95,926,309 | 0.09% | 1.66% | -4.02% | -3.74% | -1.44% | 17.51% |
| Omeros Corp. | OMER:USAOMER:USA | Stock | 1 | 773 | -9.77% | 5.83% | -5.95% | -33.46% | 158.29% | 36.08% |
* Colors indicate performance relative to the benchmark.